SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-11-300057
Filing Date
2011-11-07
Accepted
2011-11-07 17:21:42
Documents
2
Period of Report
2011-11-07
Filing Date Changed
2011-11-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d253973d8k.htm 8-K 17377
2 CERTAIN INFORMATION TO BE PROVIDED TO PROSPECTIVE DEBT FINANCING SOURCES d253973dex991.htm EX-99.1 48116
  Complete submission text file 0001193125-11-300057.txt   66607
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 111185527
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1